Growth hormone releasing hormone receptor (GHRH-R) antagonist MIA-602 modulates fibrosis and gene expression in lungs of bleomycin-treated mice

R. Jackson (Miami, United States of America), C. Zhang (Miami, United States of America), G. Delcroix (Miami, United States of America), T. Cui (Miami, United States of America), X. Zhang (Miami, United States of America), M. Mirsaeidi (Miami, United States of America), A. Lazerson (Miami, United States of America), A. Schally (Miami, United States of America)

Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia
Session: Translational aspects of idiopathic interstitial pneumonia
Session type: Thematic Poster
Number: 1283
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Jackson (Miami, United States of America), C. Zhang (Miami, United States of America), G. Delcroix (Miami, United States of America), T. Cui (Miami, United States of America), X. Zhang (Miami, United States of America), M. Mirsaeidi (Miami, United States of America), A. Lazerson (Miami, United States of America), A. Schally (Miami, United States of America). Growth hormone releasing hormone receptor (GHRH-R) antagonist MIA-602 modulates fibrosis and gene expression in lungs of bleomycin-treated mice. 1283

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Growth hormone-releasing hormone receptor antagonist MIA-602 modulates mouse lung inflammation and fibrosis due to bleomycin
Source: International Congress 2018 – New insights in the signalling pathways that underlie IPF pathophysiology
Year: 2018



Association of adrenal response in asthmatic children on inhaled steroids with polymorphisms in the genes of glucocorticoid receptor (GR) and corticotropin releasing hormone receptor 1 (CRHR1)
Source: Annual Congress 2009 - Difficult asthma in children: diagnostic and therapeutic challenges
Year: 2009


Growth hormone releasing hormone-receptor antagonist MIA-602 modulates lung inflammation, cellular signal transduction, and promotes apoptosis of mouse lung fibroblasts
Source: Virtual Congress 2020 – Translational therapeutic advances
Year: 2020


Airway neutrophils have reduced glucocorticoid receptor expression
Source: Annual Congress 2008 - Recent advances in the pathogenesis and treatment of asthma and COPD
Year: 2008


Expression of HGF receptor (c-met) in experimental hypoplastic lungs
Source: Eur Respir J 2007; 30: Suppl. 51, 134s
Year: 2007

SiRNA mediated growth factor receptors inhibition in A549 cell model of lung cancer gene therapy: insulin-like growth factor-I receptor (IGF-R1) blockade produces changes that potentially induce anti-tumor immunity
Source: Annual Congress 2008 - Biology in thoracic tumours
Year: 2008


Bronchial thermoplasty may increase steroid sensitivity by upregulating the expression of the glucocorticoid receptor
Source: Virtual Congress 2020 – Asthma pharmacology: clinical trials and mechanistic insights
Year: 2020



Effects of TH9507, a growth hormone releasing factor (GRF) analog, on functional performance in patients with COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 245s
Year: 2004

Alterated expression of leptin and its receptor in the epithelium of asthmatic patients
Source: Eur Respir J 2006; 28: Suppl. 50, 563s
Year: 2006

Synergistic action of formoterol on budesonide-generated decrease of proteoglycan production by activated lung fibroblasts is mediated via β-adrenergic receptor and is dependent on glucocorticoid receptor
Source: Eur Respir J 2004; 24: Suppl. 48, 345s
Year: 2004

Glucocorticoid-induced adrenal suppression and metabolic syndrome in glucocorticoid treated AECOPD patients related to different gene polymorphisms of the glucocorticoid receptor gene
Source: Virtual Congress 2020 – Scientific advances in airway pharmacology
Year: 2020


Growth hormone (GH) response to GH-releasing hormone (GHRH) in asthmatic patients during long-term inhaled corticosteroids (ICS) treatment
Source: Eur Respir J 2003; 22: Suppl. 45, 419s
Year: 2003

Bronchial thermoplasty upregulates the expression of the glucocorticoid receptor in tissue sections
Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science
Year: 2021


Erythropoietin (EPO) attenuates the expression of its receptor (EPO-R) in bleomycin (BLM)-induced pulmonary fibrosis (PF) in rats
Source: Annual Congress 2012 - Fibrogenesis between epithelial injury and fibroblast proliferation
Year: 2012

Differences in the glucocorticoid to progesterone receptor selectivity of inhaled glucocorticoids
Source: Eur Respir J 2006; 27: 511-516
Year: 2006



Muscarinic receptors mediate up-regulation of endothelin-1 expression in human lung fibroblasts
Source: Annual Congress 2010 - Regulation of airway pharmacology
Year: 2010

A long-acting β2-adrenergic receptor agonist increases cAMP-induced chloride secretion in human airway epithelial cells
Source: Eur Respir J 2004; 24: Suppl. 48, 555s
Year: 2004

Corticosteroid effects on cell signalling
Source: Eur Respir J 2006; 27: 413-426
Year: 2006



Proteinase-activated receptor-2 (PAR2) activation on human lung fibroblasts increases IL-6 & IL-8 mRNA expression
Source: Annual Congress 2003 - Mechanisms of lung injury: from bench to bedside
Year: 2003


Increased toll-like receptor 4 expression in mice lung tissue under intermittent hypoxia
Source: Annual Congress 2012 - Physiology, heart failure and respiration in relation to OSA
Year: 2012